We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 140 results
  1. LncRNA AFAP1-AS1 promotes M1 polarization of macrophages and osteogenic differentiation of valve interstitial cells

    Little is known about the biological functions and underlying mechanisms of long non-coding RNA AFAP1-AS1 in degenerative calcified aortic valve...

    Welai He, Hong Che, ... Ruyuan Zhou in Journal of Physiology and Biochemistry
    Article 27 May 2021
  2. Long non-coding RNA AFAP1-AS1 accelerates the progression of melanoma by targeting miR-653-5p/RAI14 axis

    Background

    Melanoma is the most aggressive skin cancer that derived from pigment cells, accounting for the majority of the skin-cancer-related deaths....

    Fei Liu, Lanting Hu, ... **ao**g Zhang in BMC Cancer
    Article Open access 30 March 2020
  3. RETRACTED ARTICLE: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

    Background

    Although trastuzumab provides significant clinical benefit for HER2-positive breast cancers, responses are limited by the emergence of...

    Mingli Han, Yuanting Gu, ... Huaying Dong in Molecular Cancer
    Article Open access 05 February 2020
  4. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway

    Background

    An increasing number of studies have demonstrated that long non-coding RNAs (lncRNAs) play pivotal roles in cancer onset and development....

    Deyao Shi, Fashuai Wu, ... Zengwu Shao in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 August 2019
  5. Metformin and long non-coding RNAs in breast cancer

    Breast cancer (BC) is the second most common cancer and cause of death in women. In recent years many studies investigated the association of long...

    Morteza Gholami, Zeynab Nickhah Klashami, ... Mahsa M. Amoli in Journal of Translational Medicine
    Article Open access 27 February 2023
  6. Retraction Note to: Exosome-mediated lncRNA AFAP1-AS1 promotes trastuzumab resistance through binding with AUF1 and activating ERBB2 translation

    This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-020-1145-5.

    Mingli Han, Yuanting Gu, ... Huaying Dong in Molecular Cancer
    Article Open access 11 July 2022
  7. Correction to: LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway

    In the original publication of this manuscript [1], Fig. 5a needs to be revised, and adjustments have also been made to the captions for Figs. 2, 4,...

    Deyao Shi, Fashuai Wu, ... Zengwu Shao in Journal of Experimental & Clinical Cancer Research
    Article Open access 28 April 2020
  8. Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice

    Background

    Pancreatic cancer (PC) represents one of the most aggressive forms of cancer. The role of long non-coding RNAs (lncRNAs) has been...

    Xu-Bo Wu, **a Feng, ... **-Qiang Liu in Journal of Experimental & Clinical Cancer Research
    Article Open access 28 February 2019
  9. MicroRNAs as Tools for Early Diagnosis and Predicting Responses to Therapy in Oesophageal Cancer

    Oesophageal cancer (EC) is an aggressive and invasive cancer with limited diagnosis and survival. EC usually occurs as either oesophageal...
    Chapter 2024
  10. Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer

    Background

    Competing endogenous RNA (ceRNA) represents a class of RNAs (e.g., long noncoding RNAs [lncRNAs]) with microRNA (miRNA) binding sites,...

    **gyi Chen, Yuxuan Song, ... Weidong Yu in BMC Cancer
    Article Open access 09 March 2021
  11. Long noncoding RNA AFAP1-AS1 acts as a competing endogenous RNA of miR-423-5p to facilitate nasopharyngeal carcinoma metastasis through regulating the Rho/Rac pathway

    Background

    Actin filament-associated protein 1 antisense RNA 1 ( AFAP1-AS1 ), a long noncoding RNA, is significantly highly expressed and associated...

    Yu Lian, Fang **ong, ... Wei **ong in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 October 2018
  12. Epigenetics of Breast Cancer

    Epigenetic modulations of gene expression, post-transcriptional silencing of messenger RNA (mRNA), and post-translational modifications of protein...
    Madhumita Roy, Jaydip Biswas, Amitava Datta in Genetics and Epigenetics of Breast Cancer
    Chapter 2023
  13. Roles of lncRNA in the diagnosis and prognosis of triple-negative breast cancer

    Breast cancer is a malignant tumor that seriously endangers women’s lives. The prognosis of breast cancer patients differs among molecular types....

    Qiuhui Yang, Yeqin Fu, ... **** Zhang in Journal of Zhejiang University-SCIENCE B
    Article 14 December 2023
  14. The role of LncRNAs in tumor immunotherapy

    Cancer immunotherapy is a major breakthrough in the history of tumor therapy in the last decade. Immune checkpoint inhibitors blocking CTLA-4/B7 or...

    Xuan Pan, Chenchen Li, Jifeng Feng in Cancer Cell International
    Article Open access 21 February 2023
  15. Retraction Note: Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway

    The authors have retracted this article [1] because there are errors in Figures 4a and 4b

    Ze-you Wang, Min Hu, ... Zhao-jian Gong in Molecular Cancer
    Article Open access 01 June 2019
  16. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non–small cell lung cancer cell proliferation by epigenetically repressing p21 expression

    Background

    Mounting evidence indicates that long noncoding RNAs (lncRNAs) could play a pivotal role in cancer biology. However, the role and molecular...

    Dandan Yin, **yi Lu, ... Erbao Zhang in Molecular Cancer
    Article Open access 24 May 2018
  17. PRC2 mediated KLF2 down regulation: a therapeutic and diagnostic axis during tumor progression

    Surgery and chemo-radiotherapy are used as the common first-line treatment options in many cancers. However, tumor relapse is observed in many cancer...

    Negin Taghehchian, Amirhosein Maharati, ... Meysam Moghbeli in Cancer Cell International
    Article Open access 08 October 2023
  18. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer

    Pancreatic cancer (PanCa) is a systemic disease with both locally advanced and malignant neoplastic phenotypes and has a poor prognosis. Among all...
    Nilabja Sikdar, Akash Bararia, ... Sudeep Banerjee in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Reference work entry 2022
  19. Long Noncoding RNA Acting as Therapeutic Target for Oxidative Stress-Induced Pancreatic Cancer

    Pancreatic cancer (PanCa) is a systemic disease with both locally advanced and malignant neoplastic phenotypes and has a poor prognosis. Among all...
    Nilabja Sikdar, Akash Bararia, ... Sudeep Banerjee in Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
    Living reference work entry 2022
  20. Long noncoding RNA TMPO-AS1 upregulates BCAT1 expression to promote cell proliferation in nasopharyngeal carcinoma via microRNA let-7c-5p

    Background

    Long non-coding RNA (lncRNA) is a group of RNA transcripts that contribute to tumor development by post-transcriptionally regulating...

    Huan Wang, Fuming Zhou, ... ** Wang in Genes and Environment
    Article Open access 27 June 2024
Did you find what you were looking for? Share feedback.